[go: up one dir, main page]

NO20090639L - Fremgangsmåte for å behandle termoregulatorisk dysfunksjon med paroksetin - Google Patents

Fremgangsmåte for å behandle termoregulatorisk dysfunksjon med paroksetin

Info

Publication number
NO20090639L
NO20090639L NO20090639A NO20090639A NO20090639L NO 20090639 L NO20090639 L NO 20090639L NO 20090639 A NO20090639 A NO 20090639A NO 20090639 A NO20090639 A NO 20090639A NO 20090639 L NO20090639 L NO 20090639L
Authority
NO
Norway
Prior art keywords
paroxetine
thermoregulatory dysfunction
treating
treating thermoregulatory
dysfunction
Prior art date
Application number
NO20090639A
Other languages
English (en)
Other versions
NO343176B1 (no
Inventor
Patricia Allison Tewes Richards
Original Assignee
Sebela International Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39030027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20090639(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sebela International Ltd filed Critical Sebela International Ltd
Publication of NO20090639L publication Critical patent/NO20090639L/no
Publication of NO343176B1 publication Critical patent/NO343176B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20090639A 2006-08-04 2009-02-10 Fremgangsmåte for å behandle termoregulatorisk dysfunksjon med paroksetin NO343176B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/499,586 US20080033050A1 (en) 2006-08-04 2006-08-04 Method of treating thermoregulatory disfunction with paroxetine
PCT/US2007/017062 WO2008019010A2 (en) 2006-08-04 2007-07-31 Method of treating thermoregulatory disfunction with paroxetine

Publications (2)

Publication Number Publication Date
NO20090639L true NO20090639L (no) 2009-02-25
NO343176B1 NO343176B1 (no) 2018-11-26

Family

ID=39030027

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090639A NO343176B1 (no) 2006-08-04 2009-02-10 Fremgangsmåte for å behandle termoregulatorisk dysfunksjon med paroksetin

Country Status (27)

Country Link
US (7) US20080033050A1 (no)
EP (2) EP2068881B1 (no)
JP (2) JP5846717B2 (no)
KR (3) KR20090040453A (no)
CN (1) CN101505759A (no)
AU (1) AU2007282065B2 (no)
BR (1) BRPI0715087A2 (no)
CA (1) CA2659577C (no)
CY (2) CY1120867T1 (no)
DK (2) DK2068881T3 (no)
ES (2) ES2699298T3 (no)
HR (2) HRP20181893T1 (no)
HU (2) HUE040481T2 (no)
IL (1) IL196844A (no)
LT (2) LT2068881T (no)
ME (1) ME00592A (no)
MX (1) MX2009001275A (no)
NO (1) NO343176B1 (no)
NZ (1) NZ574735A (no)
PL (2) PL2068881T3 (no)
PT (2) PT2719385T (no)
RS (2) RS58046B1 (no)
RU (1) RU2478379C2 (no)
SG (1) SG176452A1 (no)
SI (2) SI2068881T1 (no)
UA (1) UA96770C2 (no)
WO (1) WO2008019010A2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
US11147856B2 (en) * 2015-04-07 2021-10-19 Meiji Co., Ltd. Hot flash-suppressing agent
KR102817311B1 (ko) 2016-09-29 2025-06-09 (주)아모레퍼시픽 젖산을 유효성분으로 포함하는 열성홍조 개선용 건강식품 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
ES2058061T3 (es) * 1985-10-25 1994-11-01 Beecham Group Plc Derivado de piperidina, su preparacion y su uso como medicamento.
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5470846A (en) * 1994-01-14 1995-11-28 Sandyk; Reuven Treatment of neurological and mental disorders
JPH0837567A (ja) 1994-07-26 1996-02-06 Olympus Optical Co Ltd 情報記録媒体及び情報再生装置
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
GB9700690D0 (en) * 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
CA2291251A1 (en) * 1997-05-29 1998-12-03 Smithkline Beecham Corporation Novel process
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
SK283394B6 (sk) * 1997-06-10 2003-07-01 Synthon B. V. Zlúčeniny 4-fenylpiperidínu a jej farmaceuticky prijateľné soli, spôsob ich prípravy, liečivo s ich obsahom a ich použitie
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
CN1291889A (zh) 1998-03-02 2001-04-18 伊莱利利公司 氟西汀盐酸盐用于降低热潮红
CN1300286A (zh) 1998-03-16 2001-06-20 史密丝克莱恩比彻姆有限公司 帕罗西丁的晶形
US6699882B2 (en) * 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
US6168805B1 (en) * 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) * 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
US6369051B1 (en) * 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
CA2418038A1 (en) 2000-08-28 2002-03-07 Synthon B.V. Paroxetine compositions and processes for making the same
US6498184B2 (en) * 2000-12-05 2002-12-24 Akzo Nobel N.V. Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
ATE282594T1 (de) * 2001-01-04 2004-12-15 Ferrer Int Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
DE20100529U1 (de) 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1266659A1 (en) 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
US6956121B2 (en) * 2002-03-01 2005-10-18 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
KR20050049476A (ko) * 2002-08-14 2005-05-25 파마시아 앤드 업존 캄파니 엘엘씨 홍조를 치료하기 위한 레복세틴의 용도
US20040152710A1 (en) * 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
ITMI20022344A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
TWI267838B (en) * 2003-01-03 2006-12-01 Lite On It Corp Method to detect the type of optical disk
US20050130987A1 (en) 2003-10-14 2005-06-16 Wyeth Methods of treating vasomotor symptoms
BRPI0512182A (pt) * 2004-07-22 2008-02-19 Wyeth Corp método para o tratamento de condições e desordens do sistema nervoso
AU2005266994A1 (en) * 2004-07-22 2006-02-02 Wyeth Method for treating nervous system disorders and conditions
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
LOPRINZI C. L. et al, "Pilot evaluation of paroxetine for treating hot flashes in men.", MAYO CLINIC PROCEEDINGS, United States, (200410), vol. 79, no. 10, pages 1247 – 1251, Dated: 01.01.0001 *
STEARNS V. et al., "A Pilot Trial Assessing the Efficacy of Paroxetine hydrochloride in Controlling Hot Flashes in Breast Cancer Survivors", ANNALS OF ONCOLOGY, vol. 11 (2000), pages 17 – 22, Dated: 01.01.0001 *
STEARNS V. et al., "Paroxetine is an Effective Treatment for Hot Flashes", JOURNAL OF CLINICAL ONCOLOGY, (200510), vol. 23, pages 6919 – 6930, Dated: 01.01.0001 *

Also Published As

Publication number Publication date
BRPI0715087A2 (pt) 2015-02-10
RS57980B1 (sr) 2019-01-31
SI2068881T1 (sl) 2019-01-31
CA2659577C (en) 2015-11-24
US20170165251A1 (en) 2017-06-15
SG176452A1 (en) 2011-12-29
PT2719385T (pt) 2018-12-04
RS58046B1 (sr) 2019-02-28
HRP20181893T1 (hr) 2019-01-11
EP2719385B1 (en) 2018-08-29
EP2068881A2 (en) 2009-06-17
US20080033050A1 (en) 2008-02-07
ES2698207T3 (es) 2019-02-01
RU2478379C2 (ru) 2013-04-10
NO343176B1 (no) 2018-11-26
KR20090040453A (ko) 2009-04-24
IL196844A0 (en) 2009-12-24
JP5846717B2 (ja) 2016-01-20
US8658663B2 (en) 2014-02-25
DK2068881T3 (en) 2018-12-10
JP2014077023A (ja) 2014-05-01
WO2008019010A2 (en) 2008-02-14
LT2068881T (lt) 2018-12-10
AU2007282065B2 (en) 2013-05-09
US20140249182A1 (en) 2014-09-04
EP2068881B1 (en) 2018-08-22
US20200268733A9 (en) 2020-08-27
SI2719385T1 (sl) 2019-01-31
MX2009001275A (es) 2009-04-16
HUE040099T2 (hu) 2019-02-28
WO2008019010A3 (en) 2008-12-24
LT2719385T (lt) 2018-12-27
CY1120867T1 (el) 2019-12-11
ME00592B (me) 2011-12-20
UA96770C2 (uk) 2011-12-12
PL2068881T3 (pl) 2019-04-30
NZ574735A (en) 2011-03-31
ME00592A (en) 2011-12-20
JP5895009B2 (ja) 2016-03-30
EP2719385A1 (en) 2014-04-16
US8859576B2 (en) 2014-10-14
US9393237B2 (en) 2016-07-19
US20090275615A1 (en) 2009-11-05
PL2719385T3 (pl) 2019-06-28
CN101505759A (zh) 2009-08-12
US20180036299A1 (en) 2018-02-08
HUE040481T2 (hu) 2019-03-28
HRP20181925T1 (hr) 2019-01-11
PT2068881T (pt) 2018-11-29
CA2659577A1 (en) 2008-02-14
CY1120902T1 (el) 2019-12-11
RU2009107739A (ru) 2010-09-10
US20140235674A1 (en) 2014-08-21
EP2068881A4 (en) 2009-09-30
KR20150132888A (ko) 2015-11-26
US20150335631A1 (en) 2015-11-26
JP2009545593A (ja) 2009-12-24
ES2699298T3 (es) 2019-02-08
US8946251B2 (en) 2015-02-03
DK2719385T3 (en) 2018-12-10
IL196844A (en) 2015-11-30
KR20140098865A (ko) 2014-08-08
AU2007282065A1 (en) 2008-02-14

Similar Documents

Publication Publication Date Title
PL2034844T3 (pl) Sposób leczenia biegunkowej postaci zespołu jelita drażliwego
PL2772249T3 (pl) Sposób oraz kompozycja do leczenia nadciśnienia wewnątrzgałkowego i jaskry
EP2068927A4 (en) PROCESS FOR REDUCING EOSINOPHILLE MIRROR
CY2016017I1 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
IL195768A0 (en) Method of treating diseases with parp inhibitors
EP2379561A4 (en) MLK INHIBITORS AND METHODS OF USE
EP2094085A4 (en) ANTI-CHOLESTEROLMIC COMPOUNDS AND METHODS OF USE
ATE465169T1 (de) Hemmstoffe des progesteron-rezeptors
EP2079544A4 (en) ARSENIC ABSORBENT COMPOSITION AND METHODS OF USE
PT2046324T (pt) Tratamento e prevenção de mucosite por derivados de antocianidina
DK2034830T3 (da) Anti-vla-1-antistof til behandling af slagtilfælde
BRPI0720547A2 (pt) Inibidores de metaloprotease derivada de heterocíclico
FI20065379L (fi) Menetelmä ja sovitelma maaperän parantamiseksi ja/tai rakenteiden nostamiseksi
SI2242769T1 (sl) Protitelesa anti-kadherin-11 EC domene za zdravljenje vnetnih obolenj sklepov
EP2055399A4 (en) DORN ROD CLEANING EQUIPMENT
HRP20181925T1 (hr) Metoda za liječenje termoregulatorne disfunkcije paroksetinom
FI20075735A0 (fi) Menetelmä massan ominaisuuksien parantamiseksi
DK2246477T3 (da) Spunspæl med dobbelt t-form
FI20070746L (fi) Menetelmä kerrostumien muodostumisen kontrolloimiseksi
EP2132251A4 (en) COMPOSITION AND METHOD
EE200800056A (et) Alumiiniumšlaki mbert””tlemise meetod
BRPI0718420A2 (pt) Método de restabelecimento do efeito da incretina
TWI340287B (en) Fabrication method of periodic domain inversion structure
BRPI0821425A2 (pt) Composições e métodos para tratar disfunção erétil
EP1959946A4 (en) METHOD FOR THE TREATMENT OF ISCHEMIC ILLNESSES

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SEBELA INTERNATIONAL LIMITED, BM

CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: SEBELA IRELAND LIMITED, IE

CREP Change of representative

Representative=s name: PLOUGMANN VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

MM1K Lapsed by not paying the annual fees